Cargando…
Hidden costs of antiretroviral treatment: the public health efficiency of drug packaging
While the overall percentage of unused antiretroviral medicines returned to the hospital pharmacy is low, their cost is quite high. Adverse events, treatment failure, pharmacokinetic interactions, pregnancy, or treatment simplification are common reasons for unplanned treatment changes. Socially ine...
Autores principales: | Andreu-Crespo, Àngels, Llibre, Josep M, Cardona-Peitx, Glòria, Sala-Piñol, Ferran, Clotet, Bonaventura, Bonafont-Pujol, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532345/ https://www.ncbi.nlm.nih.gov/pubmed/26273190 http://dx.doi.org/10.2147/DDDT.S87075 |
Ejemplares similares
-
Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014) -
Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
por: Llibre, Josep M, et al.
Publicado: (2013) -
Broadening the use of antiretroviral therapy: the case for feline leukemia virus
por: Greggs, Willie M, et al.
Publicado: (2011) -
Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
por: Nachega, Jean B, et al.
Publicado: (2011) -
Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples
por: Crespo, Andrea, et al.
Publicado: (2020)